XGEVA 120 MG/1.7 ML VIAL

denosumab
$2001.5200per ML

Strength

120 mg/1.7mL

Manufacturer

Amgen Inc.

NDC

55513073021

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

1/7/2026

Active Ingredients

DENOSUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125320

On Market Since

11/18/2010

Pharmacological Classes

RANK Ligand Blocking Activity
RANK Ligand Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+3.0%

Generic Alternatives

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.